Sign In
Buy CAI
$15.48
-1.04 (-6.30%)
At Close: Jun 03, 2026
Concordia Named CAI‑NJ Community of the Year; Community Manager Earns Statewide Honor
09:00am, Wednesday, 04'th Mar 2026
EATONTOWN, N.J., March 4, 2026 /PRNewswire/ -- FirstService Residential, North America's leading residential community management company, received two prestigious honors from the Community Associati
BTSG vs. CAI: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 03'rd Mar 2026
Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. (BTSG) and Caris Life Sciences,?Inc. (CAI). But which of these two stocks presents
Caris Life Sciences (NASDAQ:CAI) Shares Gap Up After Better-Than-Expected Earnings
02:48am, Saturday, 28'th Feb 2026
Caris Life Sciences, Inc. (NASDAQ: CAI - Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $19.24, but op
Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript
11:37am, Friday, 27'th Feb 2026
Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript
These Analysts Revise Their Forecasts On Caris Life Sciences Following Q4 Earnings
08:55am, Friday, 27'th Feb 2026
Caris Life Sciences Inc. (NASDAQ: CAI) on Thursday posted better-than-expected fourth-quarter earnings.
Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise
07:00am, Friday, 27'th Feb 2026
Caris Life Sciences Inc. (NASDAQ: CAI) shares are up during Friday's premarket session following better-than-expected fourth-quarter earnings and a significant interim readout from the company's Achie
Caris Life Sciences Completes Interim Readout of Achieve 1 Study
06:00pm, Thursday, 26'th Feb 2026
Demonstrates Superior Sensitivity and Specificity of Caris Detect Results demonstrate the superiority of Whole Genome Sequencing compared to methylation-based approaches IRVING, Texas, Feb. 26, 2026
Caris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
04:05pm, Thursday, 26'th Feb 2026
Full year revenue growth of 97% driven by strong performance in molecular profiling services Expects full year 2026 revenue to be in the range of $1.0 billion to $1.02 billion IRVING, Texas, Feb. 26,
IRVING, Texas, Feb. 24, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a ne
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference
08:30am, Monday, 23'rd Feb 2026
IRVING, Texas, Feb. 23, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced tha
Caris Life Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26
08:30am, Monday, 09'th Feb 2026
IRVING, Texas, Feb. 9, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it wil
Billiontoone (NASDAQ:BLLN) & Caris Life Sciences (NASDAQ:CAI) Head to Head Review
01:26am, Monday, 02'nd Feb 2026
Billiontoone (NASDAQ: BLLN - Get Free Report) and Caris Life Sciences (NASDAQ: CAI - Get Free Report) are both mid-cap services companies, but which is the better stock? We will compare the two compan
Billiontoone (NASDAQ:BLLN) vs. Caris Life Sciences (NASDAQ:CAI) Critical Contrast
01:10am, Sunday, 01'st Feb 2026
Caris Life Sciences (NASDAQ: CAI - Get Free Report) and Billiontoone (NASDAQ: BLLN - Get Free Report) are both mid-cap services companies, but which is the better business? We will contrast the two bu
Caris Life Sciences' Real-World Data Uncovers Metastatic Breast Cancer Patient Responses and Resistance to Trastuzumab Deruxtecan
08:30am, Wednesday, 28'th Jan 2026
IRVING, Texas, Jan. 28, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study i
Critical Contrast: Caris Life Sciences (NASDAQ:CAI) & Billiontoone (NASDAQ:BLLN)
01:00am, Monday, 26'th Jan 2026
Caris Life Sciences (NASDAQ: CAI - Get Free Report) and Billiontoone (NASDAQ: BLLN - Get Free Report) are both mid-cap services companies, but which is the better business? We will contrast the two bu
